# TJ Biopharma

Source: https://onco.cc/companies/tj-biopharma/  
OnCo record `tj-biopharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

TJ Biopharma is a Chinese developer in Shanghai that sponsors 2 registered cancer trials of Uliledlimab and Sintilimab.

## Summary

TJ Biopharma appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 2, 2/3), testing Uliledlimab, Sintilimab, Pemetrexed, Toripalimab in non small cell lung cancer. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: TJ Biopharma Co., Ltd.
- Tags: ctgov-sponsor; china; registry-only
- HQ: Shanghai, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by TJ Biopharma: https://clinicaltrials.gov/search?spons=TJ%20Biopharma

## Connected records

- trials: [A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untr](https://onco.cc/trials/nct07005336/), [A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer](https://onco.cc/trials/nct06984588/)

---
JSON: https://onco.cc/api/v1/entities/tj-biopharma.json